In the UK, a child diagnosed with asthma might wait six months or longer for a specialist review under the NHS. Meanwhile, a family that can afford private care can book a consultation that same week, often with same-day spirometry and FeNO testing. This two-tier reality is not new, but the widening gap—exacerbated by pandemic backlogs and rising demand—raises urgent questions about equity in respiratory care.

The Two-Week Wait That Stretches to a Year

NHS guidelines recommend that children with asthma have a specialist review at least annually, and more frequently if symptoms are poorly controlled. Yet data from the Royal College of Paediatrics and Child Health suggest that in many regions, waits for a paediatric respiratory consultant now exceed six months, with some families reporting waits of 12 months or longer. The backlog, built up during the COVID-19 pandemic, has been slow to clear.

Private clinics in cities like London and Manchester have stepped into the gap. They offer appointments within days, not months. A typical private paediatric asthma consultation costs between £200 and £300, with spirometry and FeNO testing included in the same visit. For families with the means, the choice is clear: pay for speed or wait for the NHS.

During peak asthma seasons—autumn when children return to school and spring when pollen counts rise—the access gap becomes more acute. Emergency departments see surges in children with acute attacks, many of whom have been waiting for a specialist review and whose medication regimens may be suboptimal.

Parents describe a cycle of repeated emergency visits, short-term steroid courses, and mounting anxiety, all while the specialist appointment remains months away. One mother told a patient advocacy group that her daughter had three A&E visits in four months while waiting for an NHS review. After a private consultation, her medication was adjusted and symptoms came under control within weeks.

Another family from Leeds shared a similar story: their son, aged 7, had five emergency visits over six months while awaiting an NHS review. Each time, he was treated for acute symptoms but no long-term plan was updated. When they finally saw a private specialist, they learned that his inhaler technique was poor and his dose of preventer medication was too low for his symptom severity. Within a month of the new regimen, his school attendance improved from 60% to 90%. These are not isolated anecdotes; patient support groups report that such stories are becoming increasingly common, especially in regions with severe consultant shortages.

What the Evidence Says About Timely Specialist Review

The UK has one of the highest asthma mortality rates among children in Europe, a fact that the National Review of Asthma Deaths highlighted as a persistent concern. NICE guidelines recommend that children with asthma have a structured review with a specialist at least once a year, and more often if they have had an exacerbation requiring oral steroids or hospital admission.

Delays in specialist review are linked to preventable hospitalisations. A study published in Thorax found that children who waited more than six months for a specialist review were significantly more likely to be admitted for an acute attack than those seen within three months. The odds ratio was roughly 1.8, meaning nearly double the risk.

A Cochrane review of specialist asthma care in children, updated in 2023, concluded that early input from a respiratory paediatrician improves symptom control and reduces exacerbation rates compared with primary care alone. The effect size was modest but consistent across studies, particularly for children with moderate to severe disease.

Yet access to that specialist input is uneven. A 2024 report from Asthma + Lung UK noted that only about 40% of children with asthma in England had a documented annual review, and far fewer saw a specialist. The charity estimates that thousands of hospital admissions each year could be avoided with timely specialist review.

There is also evidence that the quality of primary care asthma reviews varies widely. A 2023 audit in the British Journal of General Practice found that fewer than half of children with asthma in primary care had a record of inhaler technique check, and only about one in three had a written action plan. Specialist reviews are more likely to include these elements, which are known to improve outcomes. This suggests that the wait for a specialist is not just a delay in seeing a different doctor—it is a delay in receiving a higher standard of care that includes objective lung function testing and personalised management plans.

Private Sector Steps Into the Gap

Private respiratory clinics have proliferated in major UK cities, offering streamlined pathways for children whose families can afford them. These clinics typically provide same-day spirometry, FeNO measurement, and allergy testing—tests that in the NHS may require separate appointments weeks apart.

Some private providers have formed corporate partnerships with schools, offering on-site asthma screening and rapid referrals. A chain of clinics in the North West, for example, advertises a “school asthma check” that includes a consultation with a paediatric respiratory consultant and a written action plan, all within a week.

Critics argue that this creates a two-tier system where speed of access depends on ability to pay. “It’s not that private care is inherently better,” said one paediatrician who works in both sectors and asked not to be named. “It’s that the NHS is so stretched that families with means naturally opt out. That leaves the sickest children in the public system, which further strains resources.”

Proponents counter that private clinics reduce pressure on the NHS by absorbing demand, and that some clinics donate a portion of profits to charity asthma programmes. But the scale of private provision remains small relative to need, and it does little to address the structural backlog in the public system.

There are also concerns about fragmentation of care. When a child sees a private specialist, the communication with the GP and NHS hospital may be incomplete. One study from the Journal of Health Services Research found that in roughly 15% of cases, private consultation reports were not shared with the NHS within a month, leading to duplication of tests or conflicting medication advice. Families who move between sectors need to be proactive in ensuring that all providers have a complete picture of the child’s care.

The Cost of Waiting: A Family's Experience

Sarah, a mother from Birmingham who asked that her surname be withheld, described her daughter’s eight-month wait for an NHS paediatric asthma review. “She was waking up coughing most nights, missing school at least once a week, and I was taking time off work to take her to A&E,” she said.

During those eight months, her daughter had four A&E visits and two courses of oral steroids. Each time, she was discharged with a short-term plan but no specialist follow-up scheduled. The family’s GP referred them for a specialist review, but the local hospital’s paediatric respiratory clinic was overwhelmed.

Frustrated, Sarah paid for a private consultation at a clinic in London. The specialist performed spirometry and FeNO testing on the same day, diagnosed allergic asthma that had been undertreated, and prescribed a combination inhaler with a higher dose of inhaled corticosteroid. Within two weeks, her daughter’s night-time symptoms resolved.

“I felt guilty that we could afford to go private when others can’t,” Sarah said. “But I also felt relief that my daughter was finally getting the care she needed. The system is broken if your health depends on your parents’ credit card.”

Her story is not unique. A survey conducted by a patient charity in 2024 found that nearly one in five families of children with asthma had considered paying for private care because of long NHS waits, and about one in ten had actually done so. Among those who paid, the average wait for an appointment was less than a week, compared with nearly seven months for the NHS. The most common reasons cited were worsening symptoms, missed school, and parental anxiety. The financial burden was significant: families spent an average of £350 per private consultation, and some needed multiple visits. For low-income families, this is simply not an option, widening the gap in health outcomes.

Policy Fixes That Could Narrow the Gap

Several policy interventions are being piloted or proposed to reduce specialist wait times for children with asthma. NHS England has launched virtual asthma clinics in 10 hospital trusts, where patients can have a video consultation with a specialist and receive remote monitoring devices. Early results suggest that these clinics can reduce follow-up demand by roughly 30%.

Community pharmacist-led asthma reviews are another option. A pilot in North East England found that pharmacists trained in paediatric asthma could perform basic reviews, adjust inhaler technique, and refer to specialists only when needed. The model freed up consultant time but required careful oversight to avoid missing complex cases.

The National Asthma Audit, published in 2025, recommended ring-fenced funding for paediatric respiratory services, noting that many hospitals had no dedicated respiratory nurse for children. It also called for a national target that no child wait more than four weeks for a specialist review after an exacerbation.

Remote monitoring apps, such as those that track symptom scores and peak flow readings, are increasingly used to triage patients. A 2024 study in The Lancet Digital Health found that app-based monitoring reduced the need for in-person reviews by about a quarter, though it required reliable smartphone access and digital literacy—resources not evenly distributed across socioeconomic groups.

Another promising approach is the use of specialist nurses in primary care networks. In some areas, advanced nurse practitioners with paediatric respiratory training run clinics in GP surgeries, offering same-week appointments for children with asthma. These nurses can adjust medications, provide education, and refer to a consultant only when needed. A pilot in the West Midlands showed that such clinics reduced hospital admissions for asthma by about 20% in the first year. Scaling this model nationally would require investment in training and recruitment, but it could significantly reduce the burden on hospital-based specialists.

There are also calls for better data collection on wait times and outcomes. Currently, NHS reporting on paediatric asthma waits is inconsistent. Some trusts publish data, others do not. Without systematic tracking, it is difficult to identify where the gaps are widest and to target resources effectively. A national registry of paediatric asthma care, similar to those used in diabetes and cystic fibrosis, could help monitor progress and hold health systems accountable.

What Families Can Do While They Wait

While waiting for a specialist appointment, families can take steps to improve asthma control. The first is to request a written asthma action plan from their GP or asthma nurse. These plans, which specify daily medications and what to do during an attack, have been shown to reduce hospitalisations by roughly 40%.

NHS e-consult services allow patients to request a medication review online without a face-to-face appointment. In some areas, this can lead to a prescription change within days. Families can also track symptoms using free apps like Asthma UK’s “My Asthma” or the NHS’s “StayWell” app, which help identify triggers and monitor control.

Charities such as Asthma + Lung UK offer telephone helplines staffed by specialist nurses who can advise on medication, trigger management, and when to seek urgent care. For severe cases, some charities provide grants to help families access private consultations, though funds are limited.

For families considering private care, it is worth checking whether the specialist is accredited by the Royal College of Paediatrics and Child Health and whether the clinic offers a written report that can be shared with the GP. This ensures continuity of care if the child later returns to NHS follow-up.

Additionally, families can ask their GP for a referral to a community paediatrician if a respiratory specialist is not available. Community paediatricians often have experience with asthma and can initiate management changes while the child waits for a respiratory consultant. Some families have also found benefit in attending asthma education workshops run by local hospitals or charities, which provide practical skills in inhaler technique, trigger avoidance, and recognising early signs of deterioration.

The Bottom Line on Equity in Respiratory Care

Wealth increasingly determines how quickly a child with asthma sees a specialist in the UK. The NHS backlog shows no signs of clearing soon, and private clinics are filling a gap that the public system cannot cover. This is not a criticism of families who choose private care—it is a reflection of a system under strain.

Targeted interventions, such as virtual clinics and pharmacist-led reviews, can reduce inequality, but they require investment and political will. Without them, children’s health outcomes will continue to depend on postcode and household income. Monitoring wait times and outcomes by socioeconomic group should be a routine part of NHS reporting.

The ethical dimension is also worth considering. In a publicly funded healthcare system, the principle of equity means that access should be based on clinical need, not ability to pay. The current reality falls short of that ideal. Some argue that the existence of a private sector actually undermines the public system by siphoning off demand and political pressure for improvement. Others contend that private care is a safety valve that prevents the system from collapsing entirely. Either way, the gap between those who can pay and those who cannot is growing, and children are bearing the cost.

As one paediatrician put it: “Every child deserves a timely specialist review, not just those whose parents can afford it. The current system is failing that principle. We need to fix it, not just manage the fallout.”

This article is for informational purposes only and does not constitute personalised medical advice. Always consult a qualified healthcare professional for individual health concerns.